June 17, 2017 1:49 am JST

Japan's drug sector to unite for emerging-market push

Tokyo will help establish financial, legal footing for cross-industry group

Japanese drugmakers and distributors, among others, will team up to gain a foothold in Vietnam and other developing economies.

TOKYO -- Around 25 Japanese companies including Eisai and Takeda Pharmaceutical plan to jointly develop and distribute medicines in emerging economies, leveraging a government partnership to take on Western giants.

The group will aim to develop markets for medicines in such regions as Asia and Africa. Members will form a corporation within the year under government leadership and kick off operations in Vietnam and Thailand in fiscal 2019.

Authorities including the Ministry of Health, Labor and Welfare will support the venture financially via a sovereign fund, as well as lay groundwork by negotiating with target countries on drug policy reform. Businesses will cooperate to build and manage pharmaceutical plants as well as to distribute products.

Such major and midsize drugmakers as Fuji Pharma and Kyowa Hakko Kirin will join wholesalers including Medipal Holdings and Alfresa Holdings. Yamato Logistics, infrastructure builder JGC and others are also expected to fill out the cross-industry group.

Underdeveloped legal frameworks make some emerging economies risky territory for companies to explore alone. But major American and European drugmakers are charging into such markets in anticipation of growing health and nursing care demand.

Team Japan is wading in as well. Tokyo's Kitahara International Hospital is set to open a rehabilitation center at a national hospital in the Vietnamese city of Hanoi, and government cooperation should speed overseas expansion by businesses.

(Nikkei)

Eisai Co., Ltd.

Japan

Market(Ticker): TKS(4523)
Sector:
Industry:
Health Technology
Pharmaceuticals: Other
Market cap(USD): 15,705.20M
Shares: 296.56M

Takeda Pharmaceutical Co., Ltd.

Japan

Market(Ticker): TKS(4502)
Sector:
Industry:
Health Technology
Pharmaceuticals: Major
Market cap(USD): 44,330.67M
Shares: 790.85M

Fuji Pharma Co., Ltd.

Japan

Market(Ticker): TKS(4554)
Sector:
Industry:
Health Technology
Pharmaceuticals: Other
Market cap(USD): 533.74M
Shares: 15.62M

Kyowa Hakko Kirin Co., Ltd.

Japan

Market(Ticker): TKS(4151)
Sector:
Industry:
Health Technology
Pharmaceuticals: Other
Market cap(USD): 10,312.13M
Shares: 576.48M

Medipal Holdings Corp.

Japan

Market(Ticker): TKS(7459)
Sector:
Industry:
Distribution Services
Medical Distributors
Market cap(USD): 4,590.78M
Shares: 244.52M

Alfresa Holdings Corp.

Japan

Market(Ticker): TKS(2784)
Sector:
Industry:
Distribution Services
Medical Distributors
Market cap(USD): 4,532.23M
Shares: 235.01M

JGC Corp.

Japan

Market(Ticker): TKS(1963)
Sector:
Industry:
Industrial Services
Engineering & Construction
Market cap(USD): 4,413.60M
Shares: 259.05M

Get Insights on Asia In Your Inbox

To read the full story, Subscribe or Log in

Get your first month for $0.99

Redeemable only through the Subscribe button below

Once subscribed, you can…

  • Read all stories with unlimited access
  • Use our smartphone and tablet apps

To read the full story, Subscribe or Log in

3 months for $9
SUBSCRIBE TODAY

Take advantage of this limited offer.
Subscribe now to get unlimited access to all articles.

To read the full story, Update your account

Resubscribe now to continue reading.
BEST OFFER:
Only US$ 9.99 per month for a full-year subscription

To read the full story, Subscribe or Log in

Once subscribed, you can…

  • Read all stories with unlimited access
  • Use our smartphone and tablet apps

To read the full story, Subscribe or Log in

3 months for $9
SUBSCRIBE TODAY

Take advantage of this limited offer.
Subscribe now to get unlimited access to all articles.

To read the full story, Update your account

We could not renew your subscription.
You need to update your payment information.